Abstract：
Battlefield pain occurs in combat casualties who experience multiple severe injuries. The nature of battlefield scenarios requires a distinct approach to battlefield pain research. A battlefield pain summit was thus convened to identify shortcomings in the current understanding of battlefield pain management, review the current state of battlefield pain research, and shape the direction of future research.
On January 10 to 11, 2022, a hybrid in-person and virtual meeting hosted by the US Army Institute of Surgical Research defined research priorities for the Combat Casualty Care Research Program\'s Battlefield Pain research portfolio. Summit participants identified the following key focus areas under the umbrella of battlefield pain research: battlefield injury patterns; use of ketamine and nonopioid analgesics; analgesic delivery systems; the impact of analgesia on performance, cognition, and survival; training methods; battlefield regional anesthesia; and research models. Preliminary statements presented during the summit were refined and rank ordered through a Delphi process.
Consensus was achieved on 7 statements addressing ideal analgesic properties, delivery systems, operational performance concerns, and pain training. Ketamine was identified as safe and effective for battlefield use, and further research into nonopioid analgesics represented a high priority.
The 7 consensus statements that emerged from this battlefield pain summit serve as a template to define the near-term research priorities for military-specific battlefield pain research.
On January 10 to 11, 2022, a hybrid in-person and virtual meeting hosted by the US Army Institute of Surgical Research defined research priorities for the Combat Casualty Care Research Program\'s Battlefield Pain research portfolio. Summit participants identified the following key focus areas under the umbrella of battlefield pain research: battlefield injury patterns; use of ketamine and nonopioid analgesics; analgesic delivery systems; the impact of analgesia on performance, cognition, and survival; training methods; battlefield regional anesthesia; and research models. Preliminary statements presented during the summit were refined and rank ordered through a Delphi process.
Consensus was achieved on 7 statements addressing ideal analgesic properties, delivery systems, operational performance concerns, and pain training. Ketamine was identified as safe and effective for battlefield use, and further research into nonopioid analgesics represented a high priority.
The 7 consensus statements that emerged from this battlefield pain summit serve as a template to define the near-term research priorities for military-specific battlefield pain research.
摘要：
战场疼痛发生在遭受多次严重伤害的战斗伤亡中。战场场景的性质需要一种独特的战场疼痛研究方法。因此召开了战场疼痛峰会，以找出当前对战场疼痛管理的理解中的不足，回顾战场疼痛研究的现状，并塑造了未来研究的方向。
1月10日至11日，2022年，由美国陆军外科研究所主办的混合面对面和虚拟会议确定了战斗伤亡研究计划的战场疼痛研究组合的研究重点。峰会参与者确定了战场疼痛研究的重点领域：战场损伤模式；氯胺酮和非阿片类镇痛药的使用；镇痛给药系统；镇痛对性能的影响，认知，和生存；训练方法；战场区域麻醉；和研究模型。峰会期间提出的初步声明经过完善，并通过Delphi程序进行了排序。
关于理想镇痛特性的7个陈述达成共识，输送系统，运营绩效问题，疼痛训练。氯胺酮被确定为安全有效的战场使用，对非阿片类镇痛药的进一步研究是当务之急。
这次战场疼痛峰会产生的7个共识声明是定义军事战场疼痛研究的近期研究重点的模板。
1月10日至11日，2022年，由美国陆军外科研究所主办的混合面对面和虚拟会议确定了战斗伤亡研究计划的战场疼痛研究组合的研究重点。峰会参与者确定了战场疼痛研究的重点领域：战场损伤模式；氯胺酮和非阿片类镇痛药的使用；镇痛给药系统；镇痛对性能的影响，认知，和生存；训练方法；战场区域麻醉；和研究模型。峰会期间提出的初步声明经过完善，并通过Delphi程序进行了排序。
关于理想镇痛特性的7个陈述达成共识，输送系统，运营绩效问题，疼痛训练。氯胺酮被确定为安全有效的战场使用，对非阿片类镇痛药的进一步研究是当务之急。
这次战场疼痛峰会产生的7个共识声明是定义军事战场疼痛研究的近期研究重点的模板。
